July 31, 2019
In The News
Mel Yeates from DDNews reports on some of Atomwise’s recent partnerships with Eli Lilly and Enamine.
Tag Archives: lilly
Read Article
June 4, 2019
In The News
Having signed a multi-year, multi-target agreement with Lilly worth potentially $550m, Atomwise CEO Abe Heifets tells Scrip the burden of proof is on AI practitioners to start producing relevant and actionable data.
June 3, 2019
Press Release
Atomwise Inc. today announced a multi-year agreement with Eli Lilly and Company to apply Atomwise’s patented artificial intelligence (AI) technology in support of Lilly’s preclinical drug discovery efforts. The companies will collaborate on up to ten drug targets selected by Lilly, with the goal of accelerating the time it takes to identify and develop potential […]